Intuitive Surgical (ISRG) Tops Q4 EPS by 85c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
Go back to Intuitive Surgical (ISRG) Tops Q4 EPS by 85c
January 22, 2016 8:37 AM EST
BTIG lifts its price target on Buy-rated Intuitive Surgical (Nasdaq: ISRG) from $575 to $600 following Q4 results and outlook issued Thursday night.
Sean Lavin noted that the firm's thesis remains intact. The analyst commented, Procedure growth, which drives system sales,... More
January 22, 2016 8:36 AM EST
Wedbush analyst, Tao Levy, thinks Intuitive Surgical (NASDAQ: ISRG) management was more upbeat than usual on its 4th quarter call where the team usually sets the bar low. No change to Outperform rating or $680 PT.
Management was upbeat and optimistic in its assessment of 2016 and expects to grow procedures in the 9%-12% range, after posting solid 15% growth in 2015. Some of this could... More
January 22, 2016 7:23 AM EST
Evercore ISI analyst Vijay Kumar reiterated a Buy rating and raised his price target on Intuitive Surgical (NASDAQ: ISRG) to $620.00 (from $600.00) following strong results after teh close.
The firm raised FY16 EPS from $20.40 to $21.30 mainly due to higher gross margins assumptions,... More
January 21, 2016 4:21 PM EST
Intuitive Surgical, Inc. (NASDAQ: ISRG) and Trumpf Medical, a division of Hill-Rom Holdings, Inc. (NYSE: HRC), today announced that the Food and Drug Administration has cleared Intuitive Surgicals 510 (k) to offer Integrated Table Motion for the da Vinci Xi Surgical System in the United States.
...
More
